Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-14-001963
Filing Date
2014-03-31
Accepted
2014-03-31 15:57:00
Documents
14
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2013_biopharmxcorp.htm 10-K 1013916
2 CERTIFICATE OF DESIGNATIONS OF SERIES A PREFERRED STOCK f10k2013ex4iii_biopharmx.htm EX-4.3 72831
3 FORM OF SUBSCRIPTION AGREEMENT f10k2013ex10xi_biopharmx.htm EX-10.11 424008
4 FORM OF INVESTOR RIGHTS AGREEMENT f10k2013ex10xii_biopharmx.htm EX-10.12 75292
5 CERTIFICATION f10k2013ex31i_biopharmx.htm EX-31.1 18209
6 CERTIFICATION f10k2013ex32i_biopharmx.htm EX-32.1 5850
13 img1.jpg GRAPHIC 299159
14 chart.jpg GRAPHIC 17381
  Complete submission text file 0001213900-14-001963.txt   5995037

Data Files

Seq Description Document Type Size
7 bpmx-20131231.xml EX-101.INS 751744
8 bpmx-20131231.xsd EX-101.SCH 34431
9 bpmx-20131231_cal.xml EX-101.CAL 25444
10 bpmx-20131231_def.xml EX-101.DEF 68568
11 bpmx-20131231_lab.xml EX-101.LAB 260830
12 bpmx-20131231_pre.xml EX-101.PRE 185584
Mailing Address 1098 HAMILTON COURT MENLO PARK CA 94025
Business Address 1098 HAMILTON COURT MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

EIN.: 593843182 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54871 | Film No.: 14730001
SIC: 1700 Construction - Special Trade Contractors